Guidelines for newborn screening of primary immunodeficiency diseases

Current Opinion in Hematology

Volumn 20, Issue 1, 2013, Pages 48-54

  Borte, Stephan ^a,b,c   Von Döbeln, Ulrika ^a   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Klinikum St Georg   (Germany)

Author keywords

Newborn screening; Primary immunodeficiency diseases; Severe combined immunodeficiency; Wilson Jungner criteria; X linked agammaglobulinaemia

Indexed keywords

AMINO ACID METABOLISM; CHILD PARENT RELATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; DRIED BLOOD SPOT TESTING; FATTY ACID METABOLISM; FLOW CYTOMETRY; GENE THERAPY; GENETIC COUNSELING; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMORAL IMMUNITY; LABORATORY DIAGNOSIS; LEUKOCYTE DIFFERENTIAL COUNT; NEWBORN SCREENING; PARENTAL STRESS; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SEVERE COMBINED IMMUNODEFICIENCY; X LINKED AGAMMAGLOBULINEMIA;

BLOOD SPECIMEN COLLECTION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT, NEWBORN; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84871989178     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32835a9130     Document Type: Review

References (27)

1. Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: An update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2011; 2:54
2. Cossu F. Genetics of SCID. Ital J Pediatr 2010; 36:76
3. Brown L, Xu-Bayford J, Allwood Z, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: The case for newborn screening. Blood 2011; 117:3243- 3246
4. Meeths M, Chiang SC, Wood SM, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood 2011; 118:5783-5793
5. Borte S, von Döbeln U, Fasth A, et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012; 119:2552-2555
6. Borte S, Wang N, Oskarsdóttir S, et al. Newborn screening for primary immunodeficiencies: Beyond SCID and XLA. Ann N Y Acad Sci 2011; 1246:118-130
7. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32:338-343
8. Wilson JMG, Jungner G. The principles and practice of screening for disease. WHO Chronicle Geneva 1968; 22:473
9. Watson M, Mann M, Lloyd-Puryear M, et al. Newborn sceening: Toward a uniform screening panel and system. Pediatrics 2006; 117:296- 307
10. Accetta Pedersen DJ, Verbsky J, Routes JM. Screening newborns for primary T-cell immunodeficiencies: Consensus and controversy. Expert Rev Clin Immunol 2011; 7:761-768
11. Pandor A, Eastham J, Beverley C, et al. Clinical effectiveness and costeffectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. Health Technol Assess 2004; 8:1-121
12. Loeber G, Burgard P, Cornel M, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2: From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis 2012; 35:613-625
13. Andermann A, Blanquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years. Bull World Health Org 2008; 86:317-319
14. Petros M. Revisiting theWilson-Jungner criteria: Howcan supplemental criteria guide public health in the era of genetic screening?Genet Med 2012; 14:129- 134
15. Plebani A, Soresina A, Rondelli R, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin Immunol 2002; 104:221-230
16. Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB. Familial haemophagocytic lymphohistiocytosis: Advances in the genetic basis, diagnosis and management. Clin Exp Immunol 2011; 163:271-283
17. Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM. Immunoglobulin treatment in primaryantibodydeficiency. Int JAntimicrobAgents2011;37:396-404
18. Bousfiha AA, Jeddane L, Ailal F, et al. Primary immunodeficiency diseases worldwide: More common than generally thought. J Clin Immunol 2012. doi: 10.1007/s10875-012-9751-7. [Epub ahead of print]
19. Verbsky J, Thakar M, Routes J. The Wisconson approach to newborn screening for severe combined immunodeficiency. J Alergy Clin Imunol 2012; 129:622-627
20. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340:508-516
21. Borte S, Janzi M, Pan-HammarstromQ, et al. Placental transfer of maternallyderived IgA precludes the use of Guthrie card eluates as a screening tool for primary immunodeficiency diseases. PLoS ONE 2012; 7:e43419
22. Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circles. J Allergy Clin Immunol 2012; 129:607-616
23. Baker MW, Grossman WJ, Laessig RH, et al. Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol 2009; 124:522-527
24. Speckmann C, Neumann C, Borte S, et al. Delayed-onset adenosine deaminase deficiency: Strategies for an early diagnosis. J Allergy Clin Immunol 2012; 130:991-994
25. McGhee SA, Stiehm ER, McCabe ER. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J Pediatr 2005; 147:603-608
26. Chan K, Davis J, Pai SY, et al. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab 2011; 104:383-389
27. Gurian E, Kinnamon D, Henry J, Waisbren S. Expanded newborn screening for biochemical disorders: The effect of a false-positive result. Pediatrics 2006; 117:1915-1921.